We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Small Interfering RNA Nanoparticles Accelerate Wound Healing in Mouse Model

By LabMedica International staff writers
Posted on 07 Apr 2015
The time required for wound healing in a mouse model was significantly shortened by treatment with nanoparticles that had been loaded with small interfering RNA (siRNA) that blocked the synthesis of the enzyme fidgetin-like 2 (FL2).

FL2, a fundamental regulator of cell migration, is a microtubule-severing enzyme that belongs to the fidgetin family, which plays varying roles in cellular development and function. More...
When active, FL2 slows the migration of cells involved in the healing process into the wound.

Investigators at Albert Einstein College of Medicine (New York, NY, USA) found that depletion of FL2 from mammalian tissue culture cells resulted in a more than two-fold increase in the rate of cell movement, due in part to a significant increase in directional motility. Immunofluorescence analyses indicated that FL2 normally localized to the cell edge, importantly to the leading edge of polarized cells, where it regulated the organization and dynamics of the microtubule cytoskeleton.

To apply these findings to live animals, the investigators facilitated the uptake of FL2-specific siRNA by utilizing a nanoparticle-based delivery platform. The siRNA caused the local depletion of FL2 in mice with both cut and burn wounds by binding to the FL2 gene's messenger RNA (mRNA), which prevented the mRNA from being translated into FL2 proteins.

The investigators reported in the March 10, 2015, online edition of the Journal of Investigative Dermatology that topical application of FL2 siRNA nanoparticles to either wound type resulted in a significant enhancement in the rate and quality of wound closure both clinically and histologically relative to controls. Taken together, these results identified FL2 as a promising therapeutic target to promote the regeneration and repair of cutaneous wounds.

"SiRNAs on their own will not be effectively taken up by cells, particularly inside a living organism" said senior author Dr. David J. Sharp, professor of physiology and biophysics at Albert Einstein College of Medicine. "They will be quickly degraded unless they are put into some kind of delivery vehicle. We saw normal, well-orchestrated regeneration of tissue, including hair follicles and the skin's supportive collagen network. Not only did the cells move into the wounds faster, but they knew what to do when they got there."

"We envision that our nanoparticle therapy could be used to speed the healing of all sorts of wounds, including everyday cuts and burns, surgical incisions, and chronic skin ulcers, which are a particular problem in the elderly and people with diabetes," said Dr. Sharp.

Related Links:

Albert Einstein College of Medicine



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.